CrossrefInfokarte
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation · 2020-05 · 26 (5) · 835-844
DOI: 10.1016/j.bbmt.2019.08.029 ↗Abstract
Kein Abstract verfügbar.
EUVIMED